Ogier provided advice to Cantor Fitzgerald. Ahascragh Distillery secured up to €4.55 million of investment by way of the Employment Investment Incentive Scheme. The private equity investment...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised ALX Oncology Holdings Inc. on the offering, and Cooley advised the underwriters. ALX Oncology Holdings Inc. (Nasdaq:ALXO) announced the pricing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Spark I Acquisition Corp. on the offering, and Ellenoff Grossman & Schole advised Cantor Fitzgerald & Co. Spark I Acquisition...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, Inc. and Davis Polk & Wardwell advised the sales agents on the offering. RAPT Therapeutics, Inc. (Nasdaq:RAPT) announced the SEC-registered at-the-market offering of its common...
You must be a Standard 1 Year member to access this content.
Gornitzky represented the underwriters on the deal. Innoviz Technologies raised U.S. $65 million in upsized underwritten follow-on public offering of ordinary shares on Nasdaq. Innoviz is a global leader...
You must be a Standard 1 Year member to access this content.
Dorsey & Whitney represented enCore, and Sidley Austin represented the agents in the offering. enCore Energy Corp. announced the establishment of a Controlled Equity Offering for the...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Verastem, while Covington advised the underwriters in the offering. Verastem, Inc. announced its $85 million public offering of common stock and pre-funded warrants....
You must be a Standard 1 Year member to access this content.
Cooley advised SI-BONE on the offering, and Latham & Watkins advised the underwriters involved. SI-BONE, Inc. has announced the pricing of its underwritten public offering of 3,775,000...
You must be a Standard 1 Year member to access this content.
Cooley advises Vaxcyte on the offering, and Latham & Watkins advises the underwriters. Vaxcyte, Inc. (Nasdaq: PCVX) has announced the pricing of an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Cooley advised Longboard Pharmaceuticals on the offering, and Latham & Watkins advised the underwriters involved. Longboard Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell represented Roivant Sciences, while Latham & Watkins represented the underwriters in the offering. Roivant Sciences (Nasdaq: ROIV) has announced its $230 million...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
You must be a Standard 1 Year member to access this content.
